Trials / Recruiting
RecruitingNCT07196410
KAN-004 for Immune-Related Diarrhea or Colitis
A Phase I Study of KAN-004 in Patients With Immune-Related Diarrhea or Colitis
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 21 (estimated)
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM) · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to evaluate the safety and tolerability of KAN-004 in patients with immune-related colitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | KAN-004 | Each dose of KAN-004 contains a consortium of bacteria isolated from the stool of healthy donors formulated as a powder in a capsule intended for oral administration |
Timeline
- Start date
- 2026-03-01
- Primary completion
- 2028-12-31
- Completion
- 2030-12-31
- First posted
- 2025-09-29
- Last updated
- 2026-04-13
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT07196410. Inclusion in this directory is not an endorsement.